A preliminary metabolomic study of patients with multiple sclerosis treated with interferon β 1a

被引：0
|
作者：
Cocco, E.
Lorefice, L.
Murgia, F.
Barberini, L.
Frau, J.
Fenu, G.
Coghe, G.
Melis, M.
Murru, M. R.
Murru, R.
Poddighe, S.
Atzori, L.
Marrosu, M. G.
机构：
来源：
MULTIPLE SCLEROSIS JOURNAL | 2013年 / 19卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：264 / 264
页数：1
相关论文
共 50 条
  • [1] Assessing the Metabolomic Profile of Multiple Sclerosis Patients Treated with Interferon Beta 1a by 1H-NMR Spectroscopy
    Lorefice, Lorena
    Murgia, Federica
    Fenu, Giuseppe
    Frau, Jessica
    Coghe, Giancarlo
    Murru, Maria Rita
    Tranquilli, Stefania
    Visconti, Andrea
    Marrosu, Maria Giovanna
    Atzori, Luigi
    Cocco, Eleonora
    [J]. NEUROTHERAPEUTICS, 2019, 16 (03) : 797 - 807
  • [2] Assessing the Metabolomic Profile of Multiple Sclerosis Patients Treated with Interferon Beta 1a by 1H-NMR Spectroscopy
    Lorena Lorefice
    Federica Murgia
    Giuseppe Fenu
    Jessica Frau
    Giancarlo Coghe
    Maria Rita Murru
    Stefania Tranquilli
    Andrea Visconti
    Maria Giovanna Marrosu
    Luigi Atzori
    Eleonora Cocco
    [J]. Neurotherapeutics, 2019, 16 : 797 - 807
  • [3] Interleukin 17 receptor in multiple sclerosis patients treated with interferon β-1a
    Michalowska-Wender, Grazyna
    Biernacka-Lukanty, Justyna
    Lasik, Zofia
    Jernas, Lukasz
    Wender, Mieczyslaw
    [J]. FOLIA NEUROPATHOLOGICA, 2011, 49 (02) : 138 - 141
  • [4] Evaluation of the risk of malignancy in patients with multiple sclerosis treated with subcutaneous interferon β-1a
    Sandberg-Wollheim, M.
    Kornmann, G.
    Moraga, M.
    Miret, M.
    Alteri, E.
    [J]. JOURNAL OF NEUROLOGY, 2010, 257 : S10 - S10
  • [5] Affinity maturation of antibodies against interferon-β in patients with multiple sclerosis treated with interferon β-1a
    Basuroski, I. Dujmovic
    Deisenhammer, F.
    [J]. MULTIPLE SCLEROSIS, 2009, 15 (09): : S244 - S245
  • [6] 1H-MRS in patients with multiple sclerosis undergoing treatment with interferon β-1a:: results of a preliminary study
    Sarchielli, P
    Presciutti, O
    Tarducci, R
    Gobbi, G
    Alberti, A
    Pelliccioli, GP
    Orlacchio, A
    Gallai, V
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1998, 64 (02): : 204 - 212
  • [7] Nephrotic syndrome in a multiple sclerosis patient treated with interferon β1a
    Auty, A
    Saleh, A
    [J]. CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 2005, 32 (03) : 366 - 368
  • [8] Cognition and fatigue in patients with relapsing multiple sclerosis treated by subcutaneous interferon β-1a: an observational study SKORE
    Benesova, Yvonne
    Tvaroh, Ales
    [J]. THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2017, 10 (01) : 18 - 32
  • [9] AUtoimmunity PRofile in INterferon β-1a treated multiple sclerosis patients.: The AUPRIN study:: comparison of 2 different dosage of subcutaneous interferon-β-1a
    Verdun, E
    Ricci, A
    Cucci, MA
    Barbero, P
    Pipieri, A
    Clerico, M
    Giordano, L
    Delfico, L
    Tassinari, T
    Motti, L
    Paciello, M
    Reggio, A
    Aimo, G
    Durelli, L
    [J]. MULTIPLE SCLEROSIS, 2004, 10 (7032): : S251 - S251
  • [10] Inosine and interferon β 1a:: preliminary results of a clinical trial in multiple sclerosis
    García, DM
    Marín, M
    López, J
    Arias, M
    Dapena, D
    Alonso-Alonso, M
    Martínez, J
    Vázquez, F
    [J]. MULTIPLE SCLEROSIS, 2004, 10 (7032): : S272 - S272
12345